Brain Natriuretic Peptide as Noninvasive Marker of the Severity of Right Ventricular Dysfunction in Chronic Thromboembolic Pulmonary Hypertension

Annals of Thoracic Surgery

Volumn 84, Issue 2, 2007, Pages 537-543

  Reesink, Herre J ^a   Tulevski, Igor I ^a   Marcus, J Tim ^b   Boomsma, Frans ^c   Kloek, Jaap J ^a   Vonk Noordegraaf, Anton ^b   Bresser, Paul ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART INDEX; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; IMMUNORADIOMETRIC ASSAY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM;

ADULT; AGED; ATHERECTOMY; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HEART CATHETERIZATION; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; PULMONARY ARTERY; THROMBOEMBOLISM; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 34447571640     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.04.006     Document Type: Article

References (27)

1. Fedullo P.F., Auger W.R., Kerr K.M., and Rubin L.J. Chronic thromboembolic pulmonary hypertension. N Engl J Med 345 (2001) 1465-1472
2. Riedel M., Stanek V., Widimsky J., and Prerovsky I. Long term follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 81 (1982) 151-158
3. Archibald C.J., Auger W.R., Fedullo P.F., et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 160 (1999) 523-528
4. Kramm T., Mayer E., Dahm M., et al. Long-term results after thromboendarterectomy for chronic pulmonary embolism. Eur J Cardiothorac Surg 15 (1999) 579-584
5. Moser K.M., Auger W.R., and Fedullo P.F. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 81 (1990) 1735-1743
6. Dartevelle P., Fadel E., Mussot S., et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 23 (2004) 637-648
7. Jamieson S.W., Kapelanski D.P., Sakakibara N., et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 76 (2003) 1457-1462
8. Bresser P., Fedullo P.F., Auger W.R., et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 23 (2004) 595-600
9. Nagaya N., Sasaki N., Ando M., et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 123 (2003) 338-343
10. Bresser P., Pepke-Zaba J., Jais X., Humbert M., and Hoeper M.M. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. Proc Am Thorac Soc 3 (2006) 594-600
11. Kreitner K.F.J., Ley S., Kauczor H.U., et al. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 232 (2004) 535-543
12. Kreitner K.F., Kunz R.P., Ley S., et al. Chronic thromboembolic pulmonary hypertension-assessment by magnetic resonance imaging. Eur Radiol 17 (2007) 11-21
13. Reesink H.J., Marcus J.T., Tulevski I.I., et al. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of MRI to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg 133 (2007) 58-64
14. Boomsma F., and van den Meiracker A.H. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res 51 (2001) 442-449
15. Law Y.M., Keller B.B., Feingold B.M., and Boyle G.J. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 95 (2005) 474-478
16. Richards A.M., Nicholls M.G., Espiner E.A., et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
17. Nagaya N., Nishikimi T., Okano Y., et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 (1998) 202-208
18. Nootens M., Kaufmann E., Rector T., et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 26 (1995) 1581-1585
19. Oosterhof T., Tulevski I.I., Vliegen H.W., Spijkerboer A.M., and Mulder B.J. Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of Fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels. Am J Cardiol 97 (2006) 1051-1055
20. Nagaya N., Nishikimi T., Uematsu M., et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102 (2000) 865-870
21. Nagaya N., Ando M., Oya H., et al. Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy. Ann Thorac Surg 74 (2002) 180-184
22. Auger W.R., Fedullo P.F., Moser K.M., Buchbinder M., and Peterson K.L. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 182 (1992) 393-398
23. Roeleveld R.J., Marcus J.T., Faes T.J.C., et al. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 234 (2005) 710-717
24. Tulevski I.I., Hirsch A., Sanson B.J., et al. Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost 86 (2001) 1193-1196
25. Simonneau G., Galie N., Rubin L.J., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 (2004) 5S-12S
26. Pieralli F., Olivotto I., Vanni S., et al. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 97 (2006) 1386-1390
27. ten Wolde M., Tulevski I.I., Mulder J.W., et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 107 (2003) 2082-2084